Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Large-scale pathways-based association study in amyotrophic lateral sclerosis.

Dalia Kasperaviciute1, Mike E Weale, Kevin V Shianna

  • 1Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK. d.kasperaviciute@prion.ucl.ac.uk

Brain : a Journal of Neurology
|April 19, 2007
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Motor Neuron Disease Register for England, Wales, and Northern Ireland: Protocol for a Population Register.

JMIR research protocols·2026
Same author

CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survival.

Brain : a journal of neurology·2026
Same author

Gut microbiota and ALS: cause, consequence or correlation? - a systematic review.

Frontiers in neuroscience·2026
Same author

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Nature genetics·2026
Same author

Digenic inheritance of mutations in SPG7 and AFG3L2 causes motor neuron and cerebellar disorders.

BMC medicine·2026
Same author

Classification of ALS molecular subtypes: a literature review on machine learning applications and their clinical value.

BMC medicine·2026
Same journal

Timing the Alzheimer's disease pathological cascade.

Brain : a journal of neurology·2026
Same journal

The significance of electrophysiological recordings from the bed nucleus of the stria terminalis in humans.

Brain : a journal of neurology·2026
Same journal

Fus-depleted oligodendrocytes reduce neuronal damage and Alzheimer's disease progression in the AppNL-G-F mouse.

Brain : a journal of neurology·2026
Same journal

Cervical lymph node biomarkers in neurodegeneration.

Brain : a journal of neurology·2026
Same journal

Lower motor neuron disorders: time for a closer look.

Brain : a journal of neurology·2026
Same journal

Reply: Cervical lymph node biomarkers in neurodegeneration.

Brain : a journal of neurology·2026
See all related articles
This summary is machine-generated.

Common genetic variations in key pathways do not significantly increase the risk for sporadic amyotrophic lateral sclerosis (ALS). This large-scale study found no strong evidence linking these genetic factors to ALS susceptibility.

Area of Science:

  • Neurogenetics
  • Neurodegenerative Diseases
  • Genomic Association Studies

Background:

  • Sporadic amyotrophic lateral sclerosis (ALS) arises from complex genetic and environmental factors.
  • Previous genetic studies for ALS yielded inconsistent findings due to small sample sizes and limited gene investigation.
  • Defects in axonal transport, vesicle trafficking, and xenobiotic metabolism are implicated in motor neuron death.

Purpose of the Study:

  • To investigate the role of common genetic variations in specific biological pathways in sporadic ALS susceptibility.
  • To conduct a pathway-based candidate gene association study with replication.
  • To assess the reliability of whole genome amplified DNA for large-scale genetic association studies.

Main Methods:

  • A case-control association study genotyped 1277 SNPs in 134 genes in 822 British ALS patients and 872 controls.

Related Experiment Videos

  • Whole genome amplified DNA was used for genotyping.
  • Replication analysis involved genotyping 19 selected SNPs in 580 German ALS patients and 361 controls.

    • Main Results:

    • No strong evidence of association was found between common variations in the investigated pathways and sporadic ALS in the discovery sample.
    • None of the suggestive associations from the initial screen were replicated in the German sample.
    • Whole genome amplified DNA demonstrated reliable genotyping efficiency and quality for large-scale studies.

    Conclusions:

    • Common genetic variations within the studied pathways are unlikely to be major contributors to sporadic ALS susceptibility.
    • The findings exclude variants with moderate effect sizes in these pathways.
    • Whole genome amplified DNA is a reliable method for large-scale genetic studies in diseases like ALS with limited sample availability.